NFA
EBS icon

Nationwide Fund Advisors’s Emergent Biosolutions EBS Stock Holding History

Nationwide Fund Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,881
Closed -$1.05M – 610
2017
Q3 		$1.05M Sell
25,881
-1,101
-4% -$39.8K ﹤0.01% 1746
2017
Q2 		$915K Sell
26,982
-18,954
-41% -$585K ﹤0.01% 1829
2017
Q1 		$1.33M Sell
45,936
-8,482
-16% -$258K 0.01% 1595
2016
Q4 		$1.79M Buy
54,418
+3,175
+6% +$95.2K 0.01% 1457
2016
Q3 		$1.62M Buy
51,243
+7,600
+17% +$221K 0.01% 1496
2016
Q2 		$1.23M Sell
43,643
-2,961
-6% -$116K 0.01% 1606
2016
Q1 		$1.69M Sell
46,604
-272
-0.6% -$9.61K 0.01% 1429
2015
Q4 		$1.88M Sell
46,876
-30,745
-40% -$1.07M 0.01% 1390
2015
Q3 		$2.21M Hold
77,621
– – 0.01% 1308
2015
Q2 		$2.56M Sell
77,621
-9,841
-11% -$305K 0.01% 1302
2015
Q1 		$2.52M Sell
87,462
-4,313
-5% -$124K 0.01% 1335
2014
Q4 		$2.5M Sell
91,775
-318
-0.3% -$7.58K 0.01% 1298
2014
Q3 		$1.96M Buy
92,093
+222
+0.2% +$5.08K 0.01% 1447
2014
Q2 		$2.06M Buy
91,871
+19,459
+27% +$453K 0.01% 1455
2014
Q1 		$1.83M Buy
72,412
+42,400
+141% +$1.07M 0.01% 1415
2013
Q4 		$690K Sell
30,012
-558
-2% -$11.6K ﹤0.01% 2077
2013
Q3 		$582K Buy
30,570
+5,959
+24% +$106K ﹤0.01% 2145
2013
Q2 		$355K Buy
+24,611
New +$356K ﹤0.01% 2198

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nationwide Fund Advisors's EBS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Emergent Biosolutions (EBS) in Q4 2017, closing a stake of 25,881 shares — an estimated $1.05M sold.

Nationwide Fund Advisors first reported a position in EBS in Q2 2013 and held it in 18 quarters. The position peaked at $2.56M in Q2 2015. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Emergent Biosolutions position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 25,881 Emergent Biosolutions shares in Q4 2017, an estimated $1.05M.
  • Nationwide Fund Advisors first reported a position in Emergent Biosolutions in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Emergent Biosolutions position peaked at $2.56M in Q2 2015.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.